In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aegerion Pharmaceuticals Inc.

Division of Amryt Pharma PLC
www.aegerion.com

Latest From Aegerion Pharmaceuticals Inc.

Ireland's Amryt Aiming For Success Stateside

With two revenue-generating products already on the market and Phase III data pending on Filsuvez for epidermolysis bullosa, CEO Joe Wiley has told Scrip that a US listing will give Amryt more visibility and credibility when it comes to future licensing and acquisition possibilities.

Strategy Rare Diseases

Sanofi Follows Charity Copay Settlement Playbook – But With Smaller Payment

Sanofi agrees to pay $11.5m and enter new corporate integrity agreement to mitigate risk and establish independent charity budget.

Advertising, Marketing & Sales Enforcement

EU Regulatory System Attacked Over Quality Of Approvals

If anyone can throw cold water on the claimed benefits of some of Europe's most recently approved medicines, it’s the international drug bulletin, Prescrire. In an assessment of 108 of the pharma industry’s latest offerings, it gives a cautious welcome to some but says that more than half bring nothing new and others could even be dangerous to patients.

Europe Drug Approval Standards

DOJ Casting Wider Net In Pharma Kickback Probes

Government is pursuing behavior it once would have taken a pass on, former DOJ attorney notes; pharma companies have inked 16 settlements in past year.

Advertising, Marketing & Sales Enforcement
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amryt Pharma PLC
  • Senior Management
  • Mary Szela, CEO
    Gregory D Perry, CFO
    Remi A Menes, Chief Commercial Officer
  • Contact Info
  • Aegerion Pharmaceuticals Inc.
    Phone: (855) 305-2347
    One Main St., Ste. 800
    Cambridge, MA 02142
    USA
UsernamePublicRestriction

Register